Rosacea
Conditions
Interventions
PPR-420:420nm IPL
PPR-540:540nm IPL
PPR-ALA-420:ALA-420nm IPL
PPR-ALA-540:ALA-540nm IPL
PPR-ALA-420-540:ALA-420nm IPL/ALA-540nm IPL
ETR-420:420nm IPL
ETR-540:540nm IPL
ETR-ALA-420:ALA-420nm IPL
ETR-ALA-540:ALA-540nm IPL
ETR-ALA-420-540:ALA-420nm IPL/ALA-540nm IPL
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients aged 20-50 years old, and the diagnosis and classification are in accordance with the standard of National Rosacea Expert Committee (NRSEC), including at least one major symptom and one secondary symptom. Main symptoms: paroxysmal flush, persistent erythema, papules, pustules, telangiectasia; Secondary symptoms: burning, tingling, dryness, plaque, swelling, eye symptoms, facial symptoms, hypertrophy and hyperplasia. Among them, the manifestations of erythema telangiectasia type: flushing, persistent erythema in the middle of the face with or without telangiectasia; Papule pustular type: persistent or transient erythema in the middle of the face, papules or pustules in the middle of the face.
Exclusion criteria
Exclusion criteria: Patients with other facial allergic or inflammatory diseases; Patients with lupus erythematosus, skin tumors, known hypersensitivity to test drugs; Patients who have taken antibiotics, tretinoin preparations, immunosuppressants and glucocorticoids within 3 months; Patients with cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system or mental diseases; Women in lactation and pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy index of inflammatory lesions;Efficacy index of VISIA; | — |
Secondary
| Measure | Time frame |
|---|---|
| FSQ;Degree of pruritus; | — |
Countries
China
Contacts
Public ContactMei Xingyu
Shanghai General Hospital
Outcome results
None listed